
Bivalent SIRT1 inhibitors
Keywords: β-NAD+; β-nicotinamide adenine dinucleotide; NAM; nicotinamide; 2â²-O-AADPR; 2â²-O-acyl-ADP-ribose; RP-HPLC; reversed-phase high performance liquid chromatography; HRMS; high-resolution mass spectrometry; EDC-MeI; 1-(3-dimethylaminopropyl)-3-ethylcarb